Merus
Merus is a clinical-stage immuno-oncology company that researches and develops bispecific antibody therapeutics for the treatment of cancer.
Business Model:
Revenue: $45.6M
Employees: 51-200
Industries / Tags:
Detailed Merus Information
Geographic Data
Address: Yalelaan 62
City: Utrecht
State: utrecht
Zip: 3584 CM
Country: NL
Financial Info
Stage:
post ipo equity
Raised Last:
$56M
Raised Total:$289M
Social
Metrics
2,231,449Website Global Rank
6,975Website Monthly Traffic
Twitter Followers
Description
Merus is a clinical-stage immuno-oncology company that researches and develops bispecific antibody therapeutics for the treatment of cancer.
Contact Phone:
Contact Email:
Merus went public on 5/20/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/20/2016
Ticker Symbol:
MRUS
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
